MPP

Guidehouse and TechSur Form SBA Mentor-Protégé Joint Venture

Retrieved on: 
Thursday, June 23, 2022

WASHINGTON, June 23, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting services to public sector and commercial clients, and technology solutions provider TechSur Solutions are pleased to announce a strategic Joint Venture (JV) and Mentor-Protégé Agreement (MPA) under the U.S. Small Business Administration (SBA) Mentor-Protégé Program (MPP) through Guidehouse's acquisition of Dovel Technologies, LLC and its JV with TechSur, 1DTS. 1DTS successfully integrates the expertise of the two firms that specialize in digital transformation, bringing cloud-native applications, solutions, and analytics to government organizations.

Key Points: 
  • Guidehouse and TechSur have combined decades of experience providing innovative solutions across the federal government to include U.S. Department of Homeland Security.
  • "TechSur offers proven core competencies in mechanizing and automating the process of IT modernization while Guidehouse brings commensurate expertise in digital transformation and IT consulting," said Guidehouse CEO Scott McIntyre.
  • "We look forward to significant collaboration through this joint venture to deliver innovative solutions for our Federal clients and team to address today's complex challenges for a more resilient tomorrow."
  • "This partnership strengthens and highlights the technical savvy and expertise of both organizations," said Amit Yadav, Chief Technology Officer of TechSur Solutions.

Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series

Retrieved on: 
Thursday, June 23, 2022

Fosun International's FTSE Russell ESG rating has improved for two consecutive years, outperforming the industry average, and has been included in the FTSE4Good Index Series for the first time.

Key Points: 
  • Fosun International's FTSE Russell ESG rating has improved for two consecutive years, outperforming the industry average, and has been included in the FTSE4Good Index Series for the first time.
  • In order to ensure the smooth and continuous progress of ESG work, Fosun has established a top-down and long-term mechanism for ESG improvement.
  • Launched in 2001, the FTSE4Good Index Series is the first index series to measure the performance of companies that meet globally recognized corporate responsibility standards.
  • Fosun International ranks No.589 on the 2022 Forbes Global 2000 List, with a MSCI ESG rating of AA.

The Villages Health Partners with KAID Health to Optimize Clinical Efficiency and Care Quality

Retrieved on: 
Wednesday, June 22, 2022

KAID Health , an AI-powered health care data analysis and provider engagement platform to optimize care quality and reimbursement, today announced its long-standing partnership with The Villages Health (TVH).

Key Points: 
  • KAID Health , an AI-powered health care data analysis and provider engagement platform to optimize care quality and reimbursement, today announced its long-standing partnership with The Villages Health (TVH).
  • KAID Healths Whole Chart Analysis platform has enabled The Villages Health providers to better engage with Medicare Advantage patients to improve overall care, said Jeffrey Lowenkron, M.D., MPP, chief medical officer, The Villages Health.
  • The Villages Health (TVH) is a patient-centered, community-based health care model with seven primary care centers and two specialty care centers, including The Center for Advanced Healthcare at Brownwood.
  • KAID Health makes care delivery more efficient, effective, and profitable for providers and their payers and Accountable Care Organization partners.

MAPS Awarded $2.2 Million to Advance Net-Zero Power Generation Technology

Retrieved on: 
Wednesday, June 22, 2022

The project will showcase NGens mandate to fund transformative manufacturing and technology projects that will leave a lasting legacy for Canadas advanced manufacturing ecosystem.

Key Points: 
  • The project will showcase NGens mandate to fund transformative manufacturing and technology projects that will leave a lasting legacy for Canadas advanced manufacturing ecosystem.
  • MAPS is developing a sustainable, transformative, net-zero power generation technology for commercial and industrial businesses: the micro-power-plant (MPP).
  • The collaboration of Burloak Technologies additive manufacturing expertise and MAPS gas turbine industrialization expertise will accelerate the development timeline bringing our breakthrough technology to market, said Daniel McGuire, CEO & Founder of MAPS.
  • McGuire Aero Propulsion Solutions (MAPS) is developing a sustainable, transformative, net-zero power generation technology for commercial and industrial businesses: the micro-power-plant (MPP).

Sunrise Senior Living Announces Strategic Appointments to its Board of Directors

Retrieved on: 
Tuesday, June 21, 2022

Sunrise Senior Living, a leading provider of senior living services, announced today the appointment of Jeff Kuster, chief executive officer of Canyon Ranch and a seasoned leader across the global health, wellness, and lifestyle industries, to its Board of Directors.

Key Points: 
  • Sunrise Senior Living, a leading provider of senior living services, announced today the appointment of Jeff Kuster, chief executive officer of Canyon Ranch and a seasoned leader across the global health, wellness, and lifestyle industries, to its Board of Directors.
  • Julie Dobson, who has served on Sunrises Board since 2018, was also named Board Chair.
  • Ms. Dobson succeeds Jeff Lozon as Board Chair, who is retiring and rotating off the Sunrise Board after seven years of service.
  • Founded in 1981, Sunrise Senior Living is credited with establishing the modern era of senior living.

Zing Data and Starburst partner, bringing big data to your phone

Retrieved on: 
Tuesday, June 21, 2022

SAN FRANCISCO, June 21, 2022 /PRNewswire/ -- Zing Data, a pioneer in collaborative business intelligence partners with Starburst, the industry leading distributed query engine to offer a native data connector.

Key Points: 
  • SAN FRANCISCO, June 21, 2022 /PRNewswire/ -- Zing Data, a pioneer in collaborative business intelligence partners with Starburst, the industry leading distributed query engine to offer a native data connector.
  • Using Zing Data and Starburst together is easy - with both companies offering generous free tiers.
  • "Zing Data and Starburst partnering makes it possible for people to use big data anywhere, even on mobile"
    Starburst the fastest SQL-based MPP query engine, which recently closed $250 M in Series D at a market valuation of $3.35B, helps companies like Comcast, FINRA, and Conde Nast unlock the value of their data.
  • Our query intelligence platform delivers an experience that 'just works'" said Zing Data CTO Sabin Thomas.

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 
Friday, June 17, 2022

ARLINGTON, Mass., June 17, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Companys 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

Key Points: 
  • ARLINGTON, Mass., June 17, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Companys 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).
  • The Company granted stock options to purchase up to an aggregate of 50,000 shares of Kala Pharmaceuticals common stock to two new employees.
  • The grants were approved by the Compensation Committee and were made as an inducement material to each employee entering into employment with Kala Pharmaceuticals in accordance with NASDAQ Listing Rule 5635(c)(4).
  • Vesting of each option is subject to such employees continued service with Kala Pharmaceuticals through the applicable vesting dates.

NCCN Policy Summit Speakers Say Flexibility in Supporting and Accommodating Cancer Patients and Caregivers Helps Workplaces Thrive

Retrieved on: 
Friday, June 17, 2022

WASHINGTON, June 17, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) convened an oncology policy summit in Washington D.C. today on the topic of building a workplace that includes support for people with cancer and their caregivers. The program, which also featured a virtual attendance option, examined how workplace norms and expectations have changed in recent years, particularly since the onset of the COVID-19 pandemic. The conversation also examined the current legal and policy landscape, plus how generational shifts and an increasing number of cancer survivors in the workforce are leading to cultural changes throughout the United States.

Key Points: 
  • "The pandemic has resulted in the transformation of virtual cancer care and a renewed interest in interventions such as home infusion of cancer therapy.
  • Panelist Rebecca V. Nellis, MPP, Executive Director, Cancer and Careers shared results from a 2021 Cancer and Careers/Harris Poll Survey.
  • NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .

Aerospike Announces Aerospike SQL Powered by Starburst

Retrieved on: 
Wednesday, June 15, 2022

MOUNTAIN VIEW, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Aerospike, Inc., the real-time data platform leader, today announced Aerospike SQL Powered by Starburst. The new solution enables customers to run massively parallel, complex SQL queries on petabyte-scale data stored in the Aerospike Real-time Data Platform. A hardened solution built on top of the popular and low-cost open-source Trino platform, the Aerospike SQL Powered by Starburst solution gives data analysts and data scientists a single point of access to federated data using existing SQL analytic tools such as Tableau, Qlik, Power BI and others.

Key Points: 
  • MOUNTAIN VIEW, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Aerospike, Inc ., the real-time data platform leader, today announced Aerospike SQL Powered by Starburst .
  • Aerospike SQL Powered by Starburst enables the global population of SQL developers and analysts to dramatically reduce the time to insight on large volumes of real-time data and drive faster decisions for better business outcomes.
  • Innovators like Aerospike and Starburst are effectively democratizing data for enterprise SQL developers, data architects and BI analysts to achieve fast, efficient SQL queries at an unlimited scale.
  • Aerospike SQL Powered by Starburst also provides both companies with new revenue streams and growth opportunities within their respective customer bases.

Kala Pharmaceuticals to Present at Jefferies Healthcare Conference

Retrieved on: 
Thursday, June 2, 2022

ARLINGTON, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies Healthcare Conference in New York, NY.

Key Points: 
  • ARLINGTON, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies Healthcare Conference in New York, NY.
  • Members from the management team are scheduled to participate in a fireside chat on Thursday, June 9, 2022 at 10:30 a.m.
  • To access the webcast and subsequent archived recording of the presentation, please visit Events in the Investors section on the Kala website at http://kalarx.com .
  • Kala is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.